- Home
- ETON vs VTSI Comparison
ETON vs VTSI Comparison
Compare ETON & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- VTSI
- Stock Information
- Founded
- ETON 2017
- VTSI 1993
- Country
- ETON United States
- VTSI United States
- Employees
- ETON N/A
- VTSI N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- VTSI Miscellaneous manufacturing industries
- Sector
- ETON Health Care
- VTSI Consumer Discretionary
- Exchange
- ETON Nasdaq
- VTSI Nasdaq
- Market Cap
- ETON 199.5M
- VTSI 70.9M
- IPO Year
- ETON 2018
- VTSI N/A
- Fundamental
- Price
- ETON $8.82
- VTSI $6.48
- Analyst Decision
- ETON Strong Buy
- VTSI Strong Buy
- Analyst Count
- ETON 3
- VTSI 2
- Target Price
- ETON $12.00
- VTSI $14.50
- AVG Volume (30 Days)
- ETON 214.1K
- VTSI 62.2K
- Earning Date
- ETON 11-11-2024
- VTSI 11-12-2024
- Dividend Yield
- ETON N/A
- VTSI N/A
- EPS Growth
- ETON N/A
- VTSI 52.41
- EPS
- ETON N/A
- VTSI 0.63
- Revenue
- ETON $31,381,000.00
- VTSI $31,848,960.00
- Revenue This Year
- ETON $19.61
- VTSI N/A
- Revenue Next Year
- ETON $35.39
- VTSI $28.48
- P/E Ratio
- ETON N/A
- VTSI $10.18
- Revenue Growth
- ETON 8.14
- VTSI N/A
- 52 Week Low
- ETON $3.03
- VTSI $4.57
- 52 Week High
- ETON $8.66
- VTSI $17.68
- Technical
- Relative Strength Index (RSI)
- ETON 76.07
- VTSI 56.57
- Support Level
- ETON $7.58
- VTSI $6.28
- Resistance Level
- ETON $8.66
- VTSI $6.70
- Average True Range (ATR)
- ETON 0.42
- VTSI 0.25
- MACD
- ETON -0.07
- VTSI 0.04
- Stochastic Oscillator
- ETON 91.49
- VTSI 77.03
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company includes installation, training, limited warranties, service agreements and related support. The company sells and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military or civilian use. The product line of the company includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire and other accessories.